The research, conducted by Grinnell biological chemistry students and led by Mark Levandoski, associate professor of chemistry, examined the family of proteins in the nervous system that respond to nicotine.
Levandoski’s team discovered that the proteins react to certain “keys,” and the new “lock” may provide new strategies for pharmaceutical companies to design drugs and an easier way to overcome nicotine addiction.
The National Institutes of Health and Research Corporation supported this protein research, and the findings were recently published in The Journal of Neuroscience. Levandoski is available for interviews to discuss this discovery in detail, including how it impacts drug design.
Cindy Deppe | Source: Newswise Science News
Further information: www.grinnell.edu
Further Reports about: Biological Chemistry > Drug design > Grinnell > nicotine > nicotine addiction > Protein
More articles from Life Sciences:
Scientists Unravel Evolution of Highly Toxic Box Jellyfish
20.11.2009 | NOAA Fisheries Northeast Fisheries Science Center
Texas A&M Researchers Examine How Viruses Destroy Bacteria
20.11.2009 | Texas A&M University
Scientists Unravel Evolution of Highly Toxic Box Jellyfish
20.11.2009 | Life Sciences
When good companies do bad things: Examining illegal corporate behavior
20.11.2009 | Business and Finance
UCR plant scientist's research spawns new discoveries showing how crops survive drought
20.11.2009 | Agricultural and Forestry Science
Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients
20.11.2009 | Event News
'Golden Age' for clinical psychology in Northern Ireland
20.11.2009 | Event News
New Perspectives in Marine Anti-Fouling Research
11.11.2009 | Event News